On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Boehringer Ingelheim (France)

InstitutionResearch output, impact & collaborations

Boehringer Ingelheim (France) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Boehringer Ingelheim (France)?

ScholarIQrecord summary

Boehringer Ingelheim (France) is a research organisation in Paris, FR. OpenAlex records 1,808 works and 207,219 citations for it. 611 researchers list it as their most recent affiliation.

How many works does Boehringer Ingelheim (France) have?

ScholarIQindexed works

Boehringer Ingelheim (France) has 1,808 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Boehringer Ingelheim (France) have?

ScholarIQcitation count

Boehringer Ingelheim (France) has 207,219 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Boehringer Ingelheim (France)?

ScholarIQresearcher count

Boehringer Ingelheim (France) has 611 researchers in the ScholarIQ index.

What is the average h-index at Boehringer Ingelheim (France)?

ScholarIQavg h-index

Boehringer Ingelheim (France) has an average h-index of 11 in OpenAlex.

What is the ROR of Boehringer Ingelheim (France)?

ScholarIQror

The ROR for Boehringer Ingelheim (France) is on the source record.

What is the OpenAlex record for Boehringer Ingelheim (France)?

ScholarIQopenalex

The OpenAlex for Boehringer Ingelheim (France) is on the source record.

Who are the most-cited researchers behind Boehringer Ingelheim (France)?

ScholarIQtop researchers by citations
1
Effie Kuti · Diabetes Treatment and Management
38 works519 citations

What are the most-cited papers on Boehringer Ingelheim (France)?

ScholarIQmost cited works
Burden of hospitalization for heart failure in the United States: a systematic literature review
Katherine M. Osenenko, Effie Kuti, Alison Deighton, Pratik Pimple, Shelagh M. Szabo
Journal of Managed Care & Specialty Pharmacy. 202277 CitationsOPEN ACCESS
Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial
Odette S. Reifsnider, Anuraag R. Kansal, Christoph Wanner, Egon Pfarr, Audrey Koitka‐Weber, Sarah Brand, Matthew Stargardter, Cheng Wang, Effie Kuti, Anastasia Ustyugova
American Journal of Kidney Diseases. 202150 CitationsOPEN ACCESS
Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease
Sandhya Mehta, Sabyasachi Ghosh, Stephen Sander, Effie Kuti, William K. Mountford
Journal of Managed Care & Specialty Pharmacy. 201835 CitationsOPEN ACCESS
Length of Stay and Hospital Costs Associated with a Pharmacodynamic‐Based Clinical Pathway for Empiric Antibiotic Choice for Ventilator‐Associated Pneumonia
Anthony M. Nicasio, Kathryn J. Eagye, Effie Kuti, David P. Nicolau, Joseph L. Kuti
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 201032 Citations

How much of the research on Boehringer Ingelheim (France) is open access?

ScholarIQopen access share
55%OPEN ACCESS
Gold
0%
Green
18%
Hybrid
18%
Bronze
18%
Closed
45%

Related on ScholarIQ

470M+ articles · 14-day free trial